Interestingly, a genome-wide CRISPR/Cas9 screening performed in mouse primary leukemia cells expressing both FLT3-ITD and MLL-AF9 fusion genes identified besides METTL3 and METTL14 also METTL16 as critical gene for AML survival (41). The gene discussed is METTL3; the disease is acute myeloid leukemia.